Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Paulus Kirchhof; Gregory Lip; IC Van Gelder; J Bax; E Hylek; S Kääb; U Schotten; K Wegscheider; G Boriani; M Ezekowitz; H Diener; H Heidbuchel; Deirdre Lane; L Mont; S Willems; P Dorian; P Vardas; G Breithardt; AJ Camm

doi:10.1160/TH11-07-0517

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Paulus Kirchhof, Gregory Lip, IC Van Gelder, J Bax, E Hylek, S Kääb, U Schotten, K Wegscheider, G Boriani, M Ezekowitz, H Diener, H Heidbuchel, Deirdre Lane, L Mont, S Willems, P Dorian, P Vardas, G Breithardt, AJ Camm

Cardiovascular Sciences

Research output: Contribution to journal › Article

73 Citations (Scopus)

Abstract

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

Original language	English
Pages (from-to)	1012-9
Number of pages	8
Journal	Thrombosis and Haemostasis
Volume	106
Issue number	6
DOIs	https://doi.org/10.1160/TH11-07-0517
Publication status	Published - 30 Nov 2011

Access to Document

10.1160/TH11-07-0517

Cite this

Kirchhof, P., Lip, G., Van Gelder, IC., Bax, J., Hylek, E., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M., Diener, H., Heidbuchel, H., Lane, D., Mont, L., Willems, S., Dorian, P., Vardas, P., Breithardt, G., & Camm, AJ. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thrombosis and Haemostasis, 106(6), 1012-9. https://doi.org/10.1160/TH11-07-0517

@article{2efac80f8f4a4f73803d854ccce96a34,

title = "Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.",

abstract = "There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.",

author = "Paulus Kirchhof and Gregory Lip and {Van Gelder}, IC and J Bax and E Hylek and S K{\"a}{\"a}b and U Schotten and K Wegscheider and G Boriani and M Ezekowitz and H Diener and H Heidbuchel and Deirdre Lane and L Mont and S Willems and P Dorian and P Vardas and G Breithardt and AJ Camm",

year = "2011",

month = nov,

day = "30",

doi = "10.1160/TH11-07-0517",

language = "English",

volume = "106",

pages = "1012--9",

journal = "Thrombosis and Haemostasis",

publisher = "Schattauer",

number = "6",

}

Kirchhof, P , Lip, G, Van Gelder, IC, Bax, J, Hylek, E, Kääb, S, Schotten, U, Wegscheider, K, Boriani, G, Ezekowitz, M, Diener, H, Heidbuchel, H, Lane, D, Mont, L, Willems, S, Dorian, P, Vardas, P, Breithardt, G & Camm, AJ 2011, 'Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.', Thrombosis and Haemostasis, vol. 106, no. 6, pp. 1012-9. https://doi.org/10.1160/TH11-07-0517

TY - JOUR

T1 - Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

AU - Kirchhof, Paulus

AU - Lip, Gregory

AU - Van Gelder, IC

AU - Bax, J

AU - Hylek, E

AU - Kääb, S

AU - Schotten, U

AU - Wegscheider, K

AU - Boriani, G

AU - Ezekowitz, M

AU - Diener, H

AU - Heidbuchel, H

AU - Lane, Deirdre

AU - Mont, L

AU - Willems, S

AU - Dorian, P

AU - Vardas, P

AU - Breithardt, G

AU - Camm, AJ

PY - 2011/11/30

Y1 - 2011/11/30

N2 - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

AB - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

U2 - 10.1160/TH11-07-0517

DO - 10.1160/TH11-07-0517

M3 - Article

C2 - 22048744

VL - 106

SP - 1012

EP - 1019

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 6

ER -

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Abstract

Access to Document

Fingerprint

Cite this